These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 29714516)

  • 1. Use of Proprietary Names by Prescribers for Generic Products.
    Borders-Hemphill V; Chan IZ; Brown K; Rider B; Taylor K; Chai G
    Ther Innov Regul Sci; 2018 Mar; 52(2):256-260. PubMed ID: 29714516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Proprietary Names by Prescribers When Prescribing Over-the-Counter (OTC) Drug Products.
    Tu CM
    Ther Innov Regul Sci; 2019 Jan; 53(1):132-137. PubMed ID: 29714596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knowledge of proprietary and generic drug names among hospital prescribers: time to mandate generic prescribing?
    Davis JS; Barrett T; Harris L
    Intern Med J; 2017 Aug; 47(8):959-962. PubMed ID: 28782212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescribing generic drugs using a generic name: Are we teaching it right?
    Kamath A
    Indian J Med Ethics; 2016; 1(3):194. PubMed ID: 27474700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nomenclature and traceability debate for biosimilars: small-molecule surrogates lend support for distinguishable nonproprietary names.
    Chao J; Skup M; Alexander E; Tundia N; Macaulay D; Wu E; Mulani P
    Adv Ther; 2015 Mar; 32(3):270-83. PubMed ID: 25772256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterizing the relationship between free drug samples and prescription patterns for acne vulgaris and rosacea.
    Hurley MP; Stafford RS; Lane AT
    JAMA Dermatol; 2014 May; 150(5):487-93. PubMed ID: 24740450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should Physicians be Encouraged to use Generic Names and to Prescribe Generic Drugs?
    Riaz H; Krasuski RA
    Am J Cardiol; 2016 Jun; 117(11):1851-2. PubMed ID: 27179932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examining patterns in medication documentation of trade and generic names in an academic family practice training centre.
    Summers A; Ruderman C; Leung FH; Slater M
    BMC Med Educ; 2017 Sep; 17(1):175. PubMed ID: 28938883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low rate of generic prescribing in the Republic of Ireland compared to England and Northern Ireland: prescribers' concerns.
    McGettigan P; McManus J; O'Shea B; Chan R; Feely J
    Ir Med J; 1997; 90(4):146-7. PubMed ID: 9267094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analyzing generic and branded substitution patterns in the Netherlands using prescription data.
    Pechlivanoglou P; van der Veen WJ; Bos JH; Postma MJ
    BMC Health Serv Res; 2011 Apr; 11():89. PubMed ID: 21524312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updated trends in US brand-name and generic drug competition.
    Grabowski H; Long G; Mortimer R; Boyo A
    J Med Econ; 2016 Sep; 19(9):836-44. PubMed ID: 27064194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The art of prescribing: negotiating the decision of generic or branded medications.
    Grant M; Chapman M
    Intern Med J; 2015 Jul; 45(7):774-6. PubMed ID: 26134696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Generic drugs instead of brand drugs prescriptions--long overdue].
    Nelson S; Slørdal L; Spigset O
    Tidsskr Nor Laegeforen; 2006 Feb; 126(4):441-3. PubMed ID: 16477280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent trends in brand-name and generic drug competition.
    Grabowski H; Long G; Mortimer R
    J Med Econ; 2014 Mar; 17(3):207-14. PubMed ID: 24320785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicians' Trust in the FDA's Use of Product-Specific Pathways for Generic Drug Approval.
    Kesselheim AS; Eddings W; Raj T; Campbell EG; Franklin JM; Ross KM; Fulchino LA; Avorn J; Gagne JJ
    PLoS One; 2016; 11(10):e0163339. PubMed ID: 27768700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Landscape Analysis of Generic Availability for Oncologic Drugs.
    Kumar V; Wang F; Hu M; Kluetz P; Zhao L
    Ther Innov Regul Sci; 2023 Nov; 57(6):1279-1286. PubMed ID: 37561261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicians' generic drug prescribing behavior in district hospitals: a case of Phitsanulok, Thailand.
    Plianbangchang P; Jetiyanon K; Suttaloung C; Khumchuen L
    Pharm Pract (Granada); 2010 Jul; 8(3):167-72. PubMed ID: 25126136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disclosure of industry payments to prescribers: industry payments might be a factor impacting generic drug prescribing.
    Qian J; Hansen RA; Surry D; Howard J; Kiptanui Z; Harris I
    Pharmacoepidemiol Drug Saf; 2017 Jul; 26(7):819-826. PubMed ID: 28485111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescription pattern at a secondary health care facility in Ilorin, Nigeria.
    Akande TM; Ologe MO
    Ann Afr Med; 2007 Dec; 6(4):186-9. PubMed ID: 18354944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What's in a name? Use of brand versus generic drug names in United States outpatient practice.
    Steinman MA; Chren MM; Landefeld CS
    J Gen Intern Med; 2007 May; 22(5):645-8. PubMed ID: 17443372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.